PRISM Emerging Gene Therapy

The PRISM Emerging Gene Therapy Index tracks small/micro-cap stocks which are developing or marketing treatments that are gene-based or otherwise target genetic material. Please note the default display sorts the companies by percent daily change. Additional sorting options allow soryting by name, volume, and percent change since index inception date.

PRISM Emerging Gene Therapy IndexInception Date of 1/2/2020 at $100.00% Change (Daily)Current Index Value% Change (Inception)
0.9%$117.6017.6%
Index ComponentsTickerCurrent Price% Daily ChangeVolume (1,000s)Average Volume (1,000s)Market Cap (Millions)1/2/2020 Price% Change Since Inception 1/2/2020
Atara Biotherapeutics, Inc.ATRA$23.701.28%929850$1,842$16.4144.4%
Orchard Therapeutics plcORTX$4.74-2.27%512643$463$13.58-65.1%
Precision BioSciences, Inc.DTIL$11.611.04%550701$609$13.14-11.6%
Fortress Biotech, Inc.FBIO$2.802.94%4791,273$262$2.713.3%
Intellia Therapeutics, Inc.NTLA$41.087.82%3,295995$2,427$14.58181.8%
Bellicum Pharmaceuticals, Inc.BLCM$3.07-4.95%584202$19$15.10-79.7%
MeiraGTx Holdings plcMGTX$14.112.99%137154$613$19.72-28.4%
Stoke Therapeutics, Inc.STOK$46.02-6.65%166121$1,673$26.5473.4%
Allogene Therapeutics, Inc.ALLO$31.50-1.41%725696$4,419$26.2220.1%
AVROBIO, Inc.AVRO$13.50-2.17%572261$560$20.61-34.5%
Mustang Bio, Inc.MBIO$3.884.3%2,7821,720$255$4.10-5.4%
ZIOPHARM Oncology, Inc.ZIOP$2.79-2.11%2,0301,504$598$4.62-39.6%
Editas Medicine, Inc.EDIT$31.56-1.07%1,168904$1,967$29.447.2%
Solid Biosciences Inc.SLDB$3.768.99%1,3714,125$227$4.43-15.1%
NeuBase Therapeutics, Inc.NBSE$8.197.62%462179$189$6.9018.7%
Celyad SACYAD$9.08-5.61%246$127$11.25-19.3%
Homology Medicines, Inc.FIXX$9.77-0.51%210411$442$20.53-52.4%